{"transactions":[{"id":3222227,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-06T21:42:55.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020."}],"balance_after":250000,"derivative":{"exercise_price":3.78,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-20-007447","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320007447/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-04"}},{"id":3222226,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-06T21:42:55.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":247480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an additional 1,555 shares of common stock previously acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":255183,"source":{"system":"sec-edgar","filing":"0000899243-20-007447","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320007447/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-04"}},{"id":3226815,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-05T00:46:51.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":247480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020."}],"balance_after":247480,"derivative":{"exercise_price":3.78,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":247480},"source":{"system":"sec-edgar","filing":"0000899243-20-007064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320007064/doc4.xml","form_type":"4"}},{"id":3226814,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-05T00:46:51.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an additional 1,555 shares of common stock previously acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":257703,"source":{"system":"sec-edgar","filing":"0000899243-20-007064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924320007064/doc4.xml","form_type":"4"}},{"id":3419350,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2019-09-09T20:37:00.000Z","date":"2019-09-05","kind":"purchase","acquired":true,"shares":4329,"price":4.68,"value":20259.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,819 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019."}],"balance_after":6148,"source":{"system":"sec-edgar","filing":"0000899243-19-023128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319023128/doc4.xml","form_type":"4"}},{"id":3605873,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":150903,"kind":"person","name":"McMullin David","position":1,"cik":"0001738662","reported_name":"McMullin David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-07T22:30:27.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":45212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019."}],"balance_after":45212,"derivative":{"exercise_price":8.05,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":45212},"source":{"system":"sec-edgar","filing":"0000899243-19-006734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319006734/doc4.xml","form_type":"4"}}]}